会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • MEDICAL MATERIAL
    • 医用材料
    • US20160074023A1
    • 2016-03-17
    • US14784465
    • 2014-04-22
    • GUNZE LIMITED
    • Yuki SAKAMOTOKensuke TAKIHidetaka NAKAYAMANoriko KAWADA
    • A61B17/00A61B17/12
    • A61B17/0057A61B17/12113A61B17/12172A61B17/12177A61B2017/00004A61B2017/00575A61B2017/00592A61B2017/00606A61B2017/00623A61B2017/00942
    • There is provided a defect hole closing material which achieves minimally invasive medical treatment for Atrial Septal Defect, and poses little possibility of occurrence of a failure in the body in some distant future.The defect hole closing material (100) comprises two bioabsorbable material-made cylindrical bodies (the first cylindrical section (110) and the second cylindrical section (120)) having a mesh-like structure in the form of an hourglass shape, a numeral “8” shape, a double spindle shape, or a peanut shape. With the first end (112) kept held securely, the second end, or the other end (122) is pulled toward the first end (112) by operating the string (140), whereupon the cylinder diameter is increased, and also the first cylindrical section (110) and the second cylindrical section (120) move close to each other with respect to the substantially central section (130) serving as a center.
    • 提供了一种缺陷闭孔材料,其实现了心房间隔缺损的微创治疗,并且在不久的将来几乎不会发生身体失败的可能性。 缺陷孔闭合材料(100)包括两个生物可吸收材料制造的圆柱体(第一圆柱形部分(110)和第二圆柱形部分(120)),其具有沙漏形状的网状结构,数字“ 8“形,双锭形或花生形。 在第一端(112)保持牢固地保持的情况下,通过操作串(140)将第二端或另一端(122)拉向第一端(112),于是缸直径增加,而第一端 圆柱形部分(110)和第二圆柱形部分(120)相对于用作中心的大致中心部分(130)彼此靠近移动。
    • 4. 发明申请
    • METHOD FOR PRODUCING SUSTAINED-RELEASE DRUG, AND SUSTAINED-RELEASE DRUG
    • US20210283058A1
    • 2021-09-16
    • US16334587
    • 2017-08-31
    • GUNZE LIMITED
    • Hidetaka NAKAYAMA
    • A61K9/16A61K9/19A61K31/727
    • The present invention aims to provide a method for producing a sustained-release drug which includes allowing a medicinal ingredient to be supported on a porous body containing a bioabsorbable polymer and which can control the releasing rate of the medicinal ingredient. The present invention also aims to provide a sustained-release drug. The present invention is directed to a method for producing a sustained-release drug, including: a solution preparing step of preparing a medicinal ingredient-bioabsorbable polymer solution having a medicinal ingredient uniformly dispersed therein and a bioabsorbable polymer dissolved therein, using the bioabsorbable polymer, the medicinal ingredient, a solvent 1 that is a poor solvent having a lower solvency for the bioabsorbable polymer, a solvent 2 that is a good solvent having a higher solvency for the bioabsorbable polymer and is incompatible with the solvent 1, and a common solvent 3 compatible with the solvent 1 and the solvent 2; a precipitating step of cooling the medicinal ingredient-bioabsorbable polymer solution to precipitate a porous body containing the bioabsorbable polymer and the medicinal ingredient; and a freeze-drying step of freeze-drying the porous body containing the bioabsorbable polymer and the medicinal ingredient to provide a sustained-release drug containing a porous body supporting the medicinal ingredient, wherein one or two or more common solvents 3 are used, and a releasing rate of the medicinal ingredient of the resulting sustained-release drug is controlled by adjusting a type and a mixing ratio of the one or two or more common solvents 3.